resveratrol has been researched along with tacrolimus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Chung, BH; Doh, KC; Kim, BM; Kim, KW; Yang, CW | 1 |
2 other study(ies) available for resveratrol and tacrolimus
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression.
Topics: Adult; AMP-Activated Protein Kinases; Animals; Cell Differentiation; Cell Proliferation; Cells, Cultured; Graft Survival; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Male; Mice; Resveratrol; Skin Transplantation; Tacrolimus; Th17 Cells; TOR Serine-Threonine Kinases | 2019 |